simvastatin has been researched along with Erectile Dysfunction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Q; Ding, F; Guo, C; Li, H; Ouyang, Q; Shan, C; Shen, W; Wu, X; Zhang, Y; Zheng, J; Zhou, Z | 1 |
| Li, H; Zhang, HY; Zhang, Y; Zhang, Z | 1 |
| Drummond, ID; Turtle, EJ; Webb, DJ | 1 |
| Collard, JB; Kirby, M; Trivedi, D; Wellsted, DM | 1 |
| Ali, S; Kirby, M; Norman, F; Przybytniak, I; Trivedi, D; Wellsted, DM | 1 |
| Cho, SY; Kim, SW; Park, K | 1 |
| Faergeman, O; Pedersen, TR | 1 |
2 trial(s) available for simvastatin and Erectile Dysfunction
| Article | Year |
|---|---|
Simvastatin improves the sexual health-related quality of life in men aged 40 years and over with erectile dysfunction: additional data from the erectile dysfunction and statin trial.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; England; Erectile Dysfunction; Humans; Male; Middle Aged; Patient Satisfaction; Quality of Life; Reproductive Health; Simvastatin; Treatment Outcome | 2014 |
Can simvastatin improve erectile function and health-related quality of life in men aged >40 years with erectile dysfunction? Rationale and design of the Erectile Dysfunction and Statins (EDS) Trial [ISRCTN66772971](1).
Topics: Adult; Aged; Double-Blind Method; Endothelium, Vascular; Erectile Dysfunction; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Quality of Life; Simvastatin; Treatment Outcome | 2011 |
5 other study(ies) available for simvastatin and Erectile Dysfunction
| Article | Year |
|---|---|
Simvastatin alleviated diabetes mellitus-induced erectile dysfunction in rats by enhancing AMPK pathway-induced autophagy.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Diabetes Mellitus, Experimental; Erectile Dysfunction; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Penile Erection; Penis; Rats; Rats, Sprague-Dawley; Simvastatin | 2020 |
Inactivation of the Ras/MAPK/PPARĪ³ signaling axis alleviates diabetic mellitus-induced erectile dysfunction through suppression of corpus cavernosal endothelial cell apoptosis by inhibiting HMGCS2 expression.
Topics: Animals; Diabetes Mellitus, Experimental; Drug Screening Assays, Antitumor; Endothelial Cells; Erectile Dysfunction; Hydroxymethylglutaryl-CoA Synthase; Male; MAP Kinase Signaling System; Penis; PPAR gamma; ras Proteins; Rats, Sprague-Dawley; RNA, Small Interfering; Simvastatin | 2019 |
Improvement in symptoms of peripheral arterial disease with sildenafil therapy.
Topics: Anticholesteremic Agents; Erectile Dysfunction; Exercise Therapy; Humans; Intermittent Claudication; Male; Middle Aged; Peripheral Arterial Disease; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Scotland; Sildenafil Citrate; Simvastatin; Sulfones; Treatment Outcome; Walking | 2013 |
Erectile response to type 5 phosphodiesterase inhibitor could be preserved with the addition of simvastatin to conventional insulin treatment in rat model of diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Erectile Dysfunction; Insulin; Male; Nitric Oxide Synthase Type III; Penile Erection; Phosphodiesterase 5 Inhibitors; Pyrimidinones; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Simvastatin; Sulfonamides | 2011 |
Simvastatin seems unlikely to cause impotence.
Topics: Erectile Dysfunction; Humans; Hypolipidemic Agents; Male; Simvastatin | 1999 |